We have been awarded a £1.75 million design and build contract for a new pharmacy and aseptic suite for chemotherapy and clinical trial/emerging therapy at Weston Park Hospital in Sheffield. We will take on the role of principal designer and principal contractor for the project, which builds on our formidable track record in designing, engineering, building and commissioning complex healthcare environments. This includes previous NHS facilities at London’s Guy’s & St Thomas’ and a sterile services department in the North West, along with a major hospital scheme in Qatar.
We are looking forward to attending Making Pharmaceuticals Conference on Tuesday 30th and Wednesday 1st May. The exhibition will be held at the Ricoh Arena in Coventry, and you can visit BES at stand 714. Suzy Smith and Gary Horrocks will be there to provide expert advice, showcase our portfolio and network.
Our project team recently celebrated over 1 million hours worked on the Macclesfield Packing & Logistics Project. We wouldn't have achieved this without the great effort of all staff on site, maintaining a great safety record with a fantastic level of quality. Following a site tour, everyone was treated to lunch to recognise all of the hard work that has helped us to achieve this remarkable milestone. Congratulations!
Over the years, we have assembled an innovative and experienced design team who specialises in front end and feasibility studies for pharmaceutical, life sciences and healthcare projects across the UK. Our team excels in providing regulatory compliant and aesthetically pleasing solutions that are always scrupulously tailored to the budget, time line, and ultimate goals for the project. BES’s front end capability is led by our Principal Architect, Neil Pulman who works with our clients to establish the outline scope and feasibility of a project prior to embarking on the relevant design phases.
2019 has got off to a bumper start for BES, with new contracts won by our Southern office alone totalling £6.7 million. It shows that our expansion in Milton Keynes, where our clients, team and delivery partners in the South can collaborate in a shared space at our offices while tapping into our national capabilities, is already building on the success of our Rochdale HQ across the pharmaceutical, biotech and medical sectors.
We have recently appointed a new Design Lead, Darren Wolfe to join our growing team in Milton Keynes office. The company has experienced substantial business growth over the last few years and opened the second office to facilitate further expansion and respond more quickly to the needs of our southern clients. In his role, Darren, will be responsible for building relationships with our clients, establishing their requirements and advising on the best solutions. He will be also overseeing project delivery from feasibility studies to handover and completion.
Following the successful delivery of a new R&D facility for the world leader in addiction treatment, BES were awarded a £500,000 commission to design a new oral solid dose manufacturing facility, located on the same site. Following an initial feasibility study to establish the project requirements, our Front End design team worked closely with the client from project inception to develop the design up to RIBA Stage 3.
Our new client, specialising in development of new applications for patch technology, engaged BES to undertake a front end study to understand the feasibility of locating a new IMP pilot manufacturing plant within their existing building. Our feasibility study demonstrated that the existing building could be re-modelled to form a new clinical trials facility.
Following completion of the structural slab and steelwork installations, the site is now prepared to commence the internal fit out activities, with Norwood leading the way with the innovative, highly specified, pre-fabricated partitioning system. The facility will occupy a total floor area in excess of 7,500m2 and comprises individual Primary Packing rooms with large, common secondary Packing areas.To meet the specific requirements of this qualified facility, bespoke solutions have been designed and developed.
Early cancer diagnosis, research and treatment have advanced exponentially in recent years, improving patient outcomes. As our understanding of cancer develops and treatments become increasingly sophisticated, there is a need to custom-prepare medication to meet the specific needs of the patient and their condition. This, in turn, demands increasingly sophisticated production facilities, both in the pharmaceutical manufacturing sector and in hospital environments, where biopharma best practice can provide key learnings for safe, effective and energy-efficient drug preparation suites within the healthcare campus.